| Evogene Ltd. | |
| Type: | Public |
| Traded As: | |
| Foundation: | 2002 |
| Founder: | Dr. Hagai Karchi and Dr. Rafi Meissner |
| Location: | Rehovot, Israel |
| Key People: | Sarit Firon, Chairperson of Board, Ofer Haviv, President & CEO |
| Industry: | Computational Biology |
| Subsid: | Biomica, Canonic, Lavie Bio, AgPlenus, Castera |
Evogene is a computational biology company based in Israel. Evogene Ltd. (NASDAQ:EVGN) has developed a unique computational predictive biology "CPB" platform, which leverages big data with advanced algorithms such as machine learning and other artificial intelligence (AI), while adding a deep understanding of biology and advanced biological technologies. Evogene is using its proprietary CPB platform to computationally design and develop next-generation life-science products based upon three core components: microbes, small molecules, and genetic elements.
Evogene's computational platform allows it to substantially increase the probability of successful life-science product development, increase the efficiency and reduce the toxicity of its life-science products while reducing time and cost to development. Its strategic partners include BASF (OTCQX:BASFY), Bayer (OTCPK:BAYZF), Corteva (CTVA), ICL Group Ltd. (ICL) as well as various academic and medical institutions.